{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:43:19Z","timestamp":1790516599226,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2020.09.035","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T18:56:38Z","timestamp":1601405798000},"page":"164-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology"],"prefix":"10.1016","volume":"47","author":[{"given":"Antonio","family":"Sommariva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ansaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Baiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cascinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-0636","authenticated-orcid":false,"given":"Roberto","family":"Cirocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Coccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4549-1395","authenticated-orcid":false,"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmaria","family":"Fiorentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8471-710X","authenticated-orcid":false,"given":"Roberta","family":"Gelmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero Vincenzo","family":"Lippolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Maria","family":"Pasqual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Sassaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Macr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sammartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Scaringi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejso.2020.09.035_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Canc"},{"issue":"8","key":"10.1016\/j.ejso.2020.09.035_bib2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.09.035_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies","volume":"243","author":"Koppe","year":"2006","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2020.09.035_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.ejso.2020.09.035_bib5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bjc.2013.82","article-title":"Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades","volume":"108","author":"Kerscher","year":"2013","journal-title":"Br J Canc"},{"issue":"12","key":"10.1016\/j.ejso.2020.09.035_bib6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.09.035_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.09.035_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","article-title":"Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy","volume":"38","author":"Klaver","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2020.09.035_bib9","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.09.035_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.ejso.2020.09.035_bib11","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","article-title":"Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma","volume":"24","author":"Yan","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.09.035_bib12","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1245\/s10434-009-0487-4","article-title":"A\u00a0systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin","volume":"16","author":"Cao","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.09.035_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","article-title":"Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"3","author":"Hallam","year":"2019","journal-title":"BJS Open"},{"key":"10.1016\/j.ejso.2020.09.035_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/codi.15003","article-title":"Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis","author":"Narasimhan","year":"2020","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2020.09.035_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fpubh.2016.00223","article-title":"The complexity of health service integration: a review of reviews","volume":"4","author":"Heyeres","year":"2016","journal-title":"Front Public Health"},{"issue":"12","key":"10.1016\/j.ejso.2020.09.035_bib16","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ejso.2019.07.008","article-title":"Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM)","volume":"45","author":"Larentzakis","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.09.035_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2217\/fon.12.206","article-title":"Incidence and prognosis of synchronous colorectal carcinomatosis","volume":"9","author":"Go\u00e9r\u00e9","year":"2013","journal-title":"Future Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.09.035_bib18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jso.24162","article-title":"Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: a cost-utility analysis of a hospital's initial experience and reflections on the health care system","volume":"113","author":"Naffouje","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2020.09.035_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010042","article-title":"Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases","volume":"97","author":"Simkens","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejso.2020.09.035_bib20","series-title":"The Rand\/UCLA appropriateness method user's manual","author":"Fitch","year":"2001"},{"key":"10.1016\/j.ejso.2020.09.035_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.12.034","article-title":"Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: a nationwide population-based study","volume":"75","author":"Rovers","year":"2017","journal-title":"Eur J Canc"},{"issue":"12","key":"10.1016\/j.ejso.2020.09.035_bib22","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(16)30490-9","article-title":"Treatment of colorectal peritoneal metastases requires multidisciplinary efforts","volume":"17","author":"Go\u00e9r\u00e9","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.09.035_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1245\/s10434-019-07935-2","article-title":"Colorectal peritoneal metastases treated by perioperative systemic chemotherapy and cytoreductive surgery with or without mitomycin C-based HIPEC: a comparative study Using the peritoneal surface disease severity score (PSDSS)","volume":"27","author":"Baratti","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"18_suppl","key":"10.1016\/j.ejso.2020.09.035_bib24","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","article-title":"UNICANCER phase III trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis. Prodige 7","volume":"36","author":"Quenet","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.09.035_bib25","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ejso.2013.06.002","article-title":"Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment","volume":"39","author":"Braam","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2020.09.035_bib26","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/bjs.7653","article-title":"Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases","volume":"98","author":"Mulsow","year":"2011","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.09.035_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.surg.2010.10.018","article-title":"Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis","volume":"151","author":"Matsuda","year":"2012","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ejso.2020.09.035_bib28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1245\/s10434-019-07225-x","article-title":"Strategies for managing intraoperative discovery of limited colorectal peritoneal metastases","volume":"26","author":"Mariani","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.09.035_bib29","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.09.035_bib30","first-page":"2621","article-title":"Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis","volume":"21","author":"van Oudheusden","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.09.035_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.canep.2014.04.004","article-title":"Patterns of metachronous metastases after curative treatment of colorectal cancer","volume":"38","author":"van Gestel","year":"2014","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"10.1016\/j.ejso.2020.09.035_bib32","first-page":"293","article-title":"Preoperative assessment of peritoneal carcinomatosis of colorectal origin","volume":"155","author":"Dohan","year":"2018","journal-title":"J\u00a0Vis Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.09.035_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11547-016-0682-x","article-title":"Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis","volume":"122","author":"Laghi","year":"2017","journal-title":"Radiol Med"},{"key":"10.1016\/j.ejso.2020.09.035_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2019.03.007","article-title":"MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients","volume":"114","author":"Engbersen","year":"2019","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.ejso.2020.09.035_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40644-018-0187-z","article-title":"Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases","volume":"19","author":"Dresen","year":"2019","journal-title":"Canc Imag"},{"issue":"6","key":"10.1016\/j.ejso.2020.09.035_bib36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/bjs5.50193","article-title":"Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"3","author":"Hentzen","year":"2019","journal-title":"BJS Open"},{"issue":"6","key":"10.1016\/j.ejso.2020.09.035_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/bjs.10723","article-title":"Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE)","volume":"105","author":"Passot","year":"2018","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.ejso.2020.09.035_bib38","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1245\/s10434-012-2465-5","article-title":"The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"19","author":"Sommariva","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2020.09.035_bib39","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ejso.2018.07.003","article-title":"The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)","volume":"44","author":"Bushati","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.09.035_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/codi.13593","article-title":"Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines","volume":"19","author":"Klaver","year":"2017","journal-title":"Colorectal Dis"},{"issue":"8","key":"10.1016\/j.ejso.2020.09.035_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bjs.11609","article-title":"Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance","volume":"107","author":"Mohamed","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2020.09.035_bib42","author":"Italian Association of Medical oncology"},{"issue":"6","key":"10.1016\/j.ejso.2020.09.035_bib43","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1245\/s10434-020-08315-x","article-title":"The chicago consensus on peritoneal surface malignancies: management of colorectal metastases","volume":"27","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.09.035_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","article-title":"Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer","volume":"23","author":"Faron","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.09.035_bib45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","article-title":"Mutations of RAS\/RAF proto-oncogenes impair survival after cytoreductive surgery and HIPEC for peritoneal metastasis of colorectal origin","volume":"268","author":"Schneider","year":"2018","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2020.09.035_bib46","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/SLA.0000000000001593","article-title":"Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis","volume":"263","author":"Kwakman","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.09.035_bib47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.critrevonc.2019.06.014","article-title":"Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer","volume":"142","author":"Wisselink","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.ejso.2020.09.035_bib48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejso.2018.10.542","article-title":"HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road?","volume":"45","author":"Ceelen","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.09.035_bib49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1245\/s10434-016-5712-3","article-title":"The role of neoadjuvant and adjuvant systemic chemotherapy with cytoreductive surgery and heated intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review","volume":"24","author":"Waite","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.09.035_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.critrevonc.2017.03.028","article-title":"Perioperative systemic therapy for resectable colorectal peritoneal metastases: sufficient evidence for its widespread use? A critical systematic review","volume":"114","author":"Rovers","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.ejso.2020.09.035_bib51","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1245\/s10434-018-6436-3","article-title":"Prognostic impact of R0 resection and targeted therapy for colorectal cancer with synchronous peritoneal metastasis","volume":"25","author":"Shida","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.09.035_bib52","first-page":"748","article-title":"Impact of neoadjuvant chemotherapy on the outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a multi-institutional retrospective review","volume":"9","author":"Beal","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.ejso.2020.09.035_bib53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12885-019-5545-0","volume":"19","author":"Rovers","year":"2019","journal-title":"BMC Canc"},{"issue":"8","key":"10.1016\/j.ejso.2020.09.035_bib54","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jso.23597","article-title":"Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"109","author":"Braam","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"30","key":"10.1016\/j.ejso.2020.09.035_bib55","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1200\/JCO.2008.17.3781","article-title":"Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials","volume":"26","author":"Mitry","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.09.035_bib56","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1245\/s10434-014-3647-0","article-title":"Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis","volume":"21","author":"Passot","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.09.035_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SLA.0b013e318255486a","article-title":"Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis","volume":"256","author":"Passot","year":"2012","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.09.035_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1634\/theoncologist.2019-0176","article-title":"Perspectives on treatment of metastatic colorectal cancer with immune checkpoint inhibitor therapy","volume":"25","author":"Morse","year":"2020","journal-title":"Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2020.09.035_bib59","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2009.1465","article-title":"Beyond outcomes--the appropriateness of surgical care","volume":"302","author":"Lee","year":"2009","journal-title":"J\u00a0Am Med Assoc"},{"issue":"7","key":"10.1016\/j.ejso.2020.09.035_bib60","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamasurg.2013.128","article-title":"Surgical quality measurement: an evolving science","volume":"148","author":"Merkow","year":"2013","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.ejso.2020.09.035_bib61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.soc.2018.02.009","article-title":"Learning curve, training program, and monitorization of surgical performance of peritoneal surface malignancies centers","volume":"27","author":"Kusamura","year":"2018","journal-title":"Surg Oncol Clin"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:05:25Z","timestamp":1755273925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320308076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0748798320308076"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.09.035","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}